Search Results

Pulsed-dye laser as an effective treatment for recalcitrant granulomatous rosacea and a potential regulator of CXCL9 expression.

• Authors : Maeng JE; Department of Dermatology, Ajou University School of Medicine, Suwon, Korea.; Son SW

Subjects: Chemokine CXCL9*/Chemokine CXCL9*/Chemokine CXCL9*/metabolism ; Chemokine CXCL9*/Chemokine CXCL9*/Chemokine CXCL9*/radiation effects ; Fibroblasts*/Fibroblasts*/Fibroblasts*/metabolism

• Source: The Journal of dermatology [J Dermatol] 2024 May; Vol. 51 (5), pp. 722-726. Date of Electronic Publication: 2023 Nov 27.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 7600545 Publication Model: Print-Electronic Cited Medium:

Record details

Serum CXCL9 as a potential marker of Type 1 inflammation in the context of eosinophilic asthma.

• Authors : Hasegawa T; Central Research Laboratories, Sysmex Corporation, Kobe, Japan.; Okazawa T

Subjects: Biomarkers*; Asthma/Asthma/Asthma/*blood ; Asthma/Asthma/Asthma/*diagnosis

• Source: Allergy [Allergy] 2019 Dec; Vol. 74 (12), pp. 2515-2518. Date of Electronic Publication: 2019 Jun 17.Publisher: Wiley-Blackwell Country of Publication: Denmark NLM ID: 7804028 Publication Model: Print-Electronic Cited Medium:

Record details

SIV-specific CD8+ T cells are enriched in female genital mucosa of rhesus macaques and express receptors for inflammatory chemokines.

• Authors : Cromwell MA; Division of Immunology, New England Primate Research Center, Harvard Medical School, Pine Hill Drive, Southborough, MA 01772, USA.; Carville A

Subjects: CD8-Positive T-Lymphocytes/CD8-Positive T-Lymphocytes/CD8-Positive T-Lymphocytes/*immunology ; Cervix Uteri/Cervix Uteri/Cervix Uteri/*immunology ; Chemokine CXCL9/Chemokine CXCL9/Chemokine CXCL9/*genetics

• Source: American journal of reproductive immunology (New York, N.Y. : 1989) [Am J Reprod Immunol] 2011 Mar; Vol. 65 (3), pp. 242-7. Date of Electronic Publication: 2011 Jan 12.Publisher: Wiley-Blackwell Country of Publication: Denmark NLM ID: 8912860 Publication Model: Print-Electronic Cited Medium:

Record details

Antimicrobial activity and regulation of CXCL9 and CXCL10 in oral keratinocytes.

• Authors : Marshall A; University College London, UCL Eastman Dental Institute, London, UK.; Celentano A

Subjects: Escherichia coli*; Chemokine CXCL10/Chemokine CXCL10/Chemokine CXCL10/*physiology ; Chemokine CXCL9/Chemokine CXCL9/Chemokine CXCL9/*physiology

• Source: European journal of oral sciences [Eur J Oral Sci] 2016 Oct; Vol. 124 (5), pp. 433-439. Date of Electronic Publication: 2016 Sep 27.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 9504563 Publication Model: Print-Electronic Cited Medium:

Record details

High MIG (CXCL9) plasma levels favours response to peginterferon and ribavirin in HCV-infected patients regardless of DPP4 activity.

• Authors : Johansson S; Janssen Research and Development, Beerse, Belgium.; Talloen W

Subjects: Antiviral Agents/Antiviral Agents/Antiviral Agents/*therapeutic use ; Chemokine CXCL9/Chemokine CXCL9/Chemokine CXCL9/*blood ; Dipeptidyl Peptidase 4/Dipeptidyl Peptidase 4/Dipeptidyl Peptidase 4/*blood

• Source: Liver international : official journal of the International Association for the Study of the Liver [Liver Int] 2016 Mar; Vol. 36 (3), pp. 344-52. Date of Electronic Publication: Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 101160857 Publication Model: Print-Electronic Cited

Record details

Serum chemokine receptor CXCR3 ligands are associated with progression, organ dysfunction and complications of chronic liver diseases.

• Authors : Tacke F; Medical Department III, University Hospital Aachen, Aachen, Germany.; Zimmermann HW

Subjects: Chemokine CXCL10/Chemokine CXCL10/Chemokine CXCL10/*blood ; Chemokine CXCL11/Chemokine CXCL11/Chemokine CXCL11/*blood ; Chemokine CXCL9/Chemokine CXCL9/Chemokine CXCL9/*blood

• Source: Liver international : official journal of the International Association for the Study of the Liver [Liver Int] 2011 Jul; Vol. 31 (6), pp. 840-9. Date of Electronic Publication: Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 101160857 Publication Model: Print-Electronic Cited

Record details

Correlation between cerebrospinal fluid cell count and cerebrospinal fluid level of chemokine, monokine induced by interferon-gamma in Vogt-Koyanagi-Harada disease.

• Authors : Keino H; Usui Y; Oh-i K

Subjects: Cerebrospinal Fluid/Cerebrospinal Fluid/Cerebrospinal Fluid/*cytology ; Chemokine CCL2/Chemokine CCL2/Chemokine CCL2/*cerebrospinal fluid ; Chemokine CXCL10/Chemokine CXCL10/Chemokine CXCL10/*cerebrospinal fluid

• Source: Acta ophthalmologica [Acta Ophthalmol] 2010 Mar; Vol. 88 (2), pp. e30-1. Date of Electronic Publication: 2008 Aug 11.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101468102 Publication Model: Print-Electronic Cited

Record details

Synergizing CXCL9 with BRD4‐PROTAC Using Nanochaperone Boosts Robust T Cell‐Dependent Antitumor Immune Responses for Cancer Immunotherapy.

• Authors : Chen, Jiajing; Ma, Feihe; Zhang, Yongxin

Subjects: CYTOTOXIC T cells; T cells; IMMUNE response

• Source: Advanced Functional Materials; 6/6/2024, Vol. 34 Issue 23, p1-13, 13p

Record details

Inhibition of renal fibrosis with a human CXCL9‐derived glycosaminoglycan‐binding peptide.

• Authors : Poosti, Fariba; Soebadi, Mohammad Ayodhia; Crijns, Helena

Subjects: RENAL fibrosis; PEPTIDES; GLYCOSAMINOGLYCANS

• Source: Clinical & Translational Immunology; 2022, Vol. 11 Issue 2, p1-18, 18p

Record details

Peripheral blood levels of CXCL10 are a useful marker for diabetic polyneuropathy in subjects with type 2 diabetes.

• Authors : Ascaso, Pilar; Palanca, Ana; Martinez‐Hervás, Sergio

• Source: International Journal of Clinical Practice; Aug2021, Vol. 75 Issue 8, p1-6, 6p

Record details